Cyclerion Therapeutics (CYCN) Asset Utilization Ratio (2020 - 2025)

Cyclerion Therapeutics' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.29 for Q3 2025.

• In Q3 2025, Asset Utilization Ratio rose 1310.51% year-over-year to 0.29; the TTM figure through Sep 2025 stood at 0.29 (up 1310.51% YoY), while the FY2024 annual figure was 0.17, changed N/A from the prior year.
• Asset Utilization Ratio was 0.29 for Q3 2025 at Cyclerion Therapeutics, up from 0.23 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.29 in Q3 2025 to a low of 0.01 in Q1 2021.
• Historically, Asset Utilization Ratio has averaged 0.1 across 5 years, with a median of 0.05 in 2021.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio sank 76.12% in 2023, then surged 1310.51% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.06 in 2021, then decreased by 24.01% to 0.05 in 2022, then tumbled by 56.06% to 0.02 in 2023, then surged by 944.98% to 0.22 in 2024, then soared by 33.28% to 0.29 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.29 (Q3 2025), 0.23 (Q2 2025), and 0.21 (Q1 2025), per Business Quant data.